Literature DB >> 3458257

Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma.

P G Pelicci, D M Knowles, I Magrath, R Dalla-Favera.   

Abstract

We have examined the position of the chromosomal breakpoint relative to the human c-myc gene (MYC) and the presence of other structural alterations of the same locus in 19 fresh samples of Burkitt lymphoma (BL) and 13 BL-derived cell lines. This panel includes the two pathogenetic forms of BL: the endemic (African-type) BL (eBL) and sporadic (American-type) BL (sBL). In all cases tested, including fresh samples and cell lines, structural alterations of the 5' portion of the gene were detected, suggesting that they may be necessary for c-myc activation. However, the site of chromosomal breakpoint and the type of structural alterations differ in eBL and sBL. In 16 of 18 sBL cases, chromosomal translocation truncates the gene within a 5' region that includes the first intron, the first exon, and 5' flanking sequences. Conversely, in 14 of 14 eBL samples, the chromosomal breakpoint is located outside the c-myc locus, yet the same 5' sequences are affected by several mutations identifiable by restriction enzyme polymorphisms. Different genetic mechanisms may therefore be involved in chromosomal translocation/c-myc activation, and these differences may be a function of differences in the stage of differentiation of eBL versus sBL.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3458257      PMCID: PMC323431          DOI: 10.1073/pnas.83.9.2984

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29).

Authors:  R Dalla-Favera; E P Gelmann; S Martinotti; G Franchini; T S Papas; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

2.  Non-immunoglobulin-associated DNA rearrangements in mouse plasmacytomas.

Authors:  L J Harris; R B Lang; K B Marcu
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

3.  Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient.

Authors:  R Dalla-Favera; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

Review 4.  Burkitt's lymphoma.

Authors:  J L Ziegler
Journal:  N Engl J Med       Date:  1981-09-24       Impact factor: 91.245

5.  Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumors.

Authors:  M Piechaczyk; J Q Yang; J M Blanchard; P Jeanteur; K B Marcu
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

6.  Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type.

Authors:  D Benjamin; I T Magrath; R Maguire; C Janus; H D Todd; R G Parsons
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

7.  Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.

Authors:  I T Magrath; C B Freeman; P Pizzo; J Gadek; E Jaffe; M Santaella; C Hammer; M Frank; G Reaman; L Novikovs
Journal:  J Natl Cancer Inst       Date:  1980-03       Impact factor: 13.506

8.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.

Authors:  R Dalla-Favera; M Bregni; J Erikson; D Patterson; R C Gallo; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.

Authors:  R Taub; I Kirsch; C Morton; G Lenoir; D Swan; S Tronick; S Aaronson; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma.

Authors:  G M Lenoir; J L Preud'homme; A Bernheim; R Berger
Journal:  Nature       Date:  1982-07-29       Impact factor: 49.962

View more
  70 in total

Review 1.  Molecular diagnostic approach to non-Hodgkin's lymphoma.

Authors:  D A Arber
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

Review 2.  Burkitt's lymphoma: new insights into molecular pathogenesis.

Authors:  C Bellan; S Lazzi; G De Falco; A Nyongo; A Giordano; L Leoncini
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

3.  Improved long-distance polymerase chain reaction for the detection of t(8;14)(q24;q32) in Burkitt's lymphomas.

Authors:  K Basso; E Frascella; L Zanesco; A Rosolen
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

Authors:  C Cinti; L Leoncini; A Nyongo; F Ferrari; S Lazzi; C Bellan; R Vatti; A Zamparelli; G Cevenini; G M Tosi; P P Claudio; N M Maraldi; P Tosi; A Giordano
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

5.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation.

Authors:  J Locker; M Nalesnik
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

6.  NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma.

Authors:  L Ji; M Arcinas; L M Boxer
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

7.  Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments.

Authors:  P Riboldi; G Gaidano; E W Schettino; T G Steger; D M Knowles; R Dalla-Favera; P Casali
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

8.  De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.

Authors:  A Matolcsy; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

9.  Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression.

Authors:  D Eick; G W Bornkamm
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

10.  A single nucleotide change in the c-myc internal ribosome entry segment leads to enhanced binding of a group of protein factors.

Authors:  F E Paulin; S A Chappell; A E Willis
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.